FDA Investigator Jean M Kelahan
Jean M Kelahan has conducted inspections on 89 sites in 2 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
89
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Jean M Kelahan:
Addam S Reynolds,
Alberto A Viciedo,
Allen Lou,
Althea A Williams,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Anastasia I Offordile,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie B Randow,
Annemarie Bodnar,
Arindam Dasgupta, PhD,
Atul J Agrawal,
Barbara D Wright,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Burnell M Henry,
Byungja E Marciante,
Cara M Minelli,
Cary Greene,
Charles J Chacko,
Cheryl A Grandinetti,
Christian D Lynch (CDL),
Christina N Maurino,
Christine M Cerenzio,
Christopher J Adams,
Creighton T Tuzon,
Daniel J Grabicki,
Darin S Wiegers,
David H Smith,
Dawn L Wydner,
Deborah B Nixon,
Denise M Visco, Investigator,
Dennis E Guilfoyle, PhD,
Dhaval H Patel,
Dolores Harper,
Donald L Lech,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Dr. Guang Gao, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edward D Mcdonald,
Edward O'shaughnessy,
Eliezar Ramos,
Emest F Bizjak,
Emily A Walters,
Emmanuel Jramos Maldonado,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Esteban Beltran,
Eufemia G Gonzalez,
Frank J Marciniak,
Gene D Arcy,
George Pyramides,
Gobiga Vanniyasingam,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
J David Doleski,
Jacqueline A O'shaughnessy, PhD,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James E Frye,
Jean Blackston Hill,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Jessica M Monteiro,
Joan A Loreng,
Joanne Pryzbylik,
Jonee J Mearns,
Joseph F Mcginnis, RPh,
Joseph L Despins, PhD,
Joy Rkozlowski Klena,
Juanita P Versace,
Julie D Bringger,
Kara A Scheibner, PhD,
Karen E D'orazio,
Karen F Tomaziefski,
Kassa Ayalew, MD,
Keith M Reilly,
Kelli F Dobilas,
Kelly I Anderson,
Kelly L Anderson,
Kimberly M Bigler,
Kinh Q Mac,
Kish Bolden,
Kristen E Rescigno,
Kristina L Conroy,
Kristy A Zielny,
Krystal O Ogunremi,
Kwong P Lee,
Kyle D Covill,
Lata C Mathew, PhD,
Lauren L Vajo,
LCDR Debra Emerson,
Lenahan Lenahan, Peter R,
Li Li,
Liatte Kreuger, PharmD,
Lisa Harlan,
Lisa Mathew,
Loretta Nemchik,
Marcelo O Mangalindan, Jr,
Margaret M Sands,
Maria Estrella,
Marion Michaelis,
Mariza M Jafary,
Martha T Olone,
Martin K Yau, PhD,
Mary T Carden,
Matthew A Spataro,
Mayar M Mussa,
Meihong Liu,
Melba Trivera Clavell,
Melissa A Freeman,
Melissa A Zuppe,
Melissa T Roy,
Meredith L Sheridan,
Meyer J Slobotsky,
Michael F Skelly, PhD,
Michael J Nerz,
Michael R Klapal,
Michael Serrano,
Michael Skelly,
Mike M Rashti,
Mohsen Rajabi Abhari, FDA,
Monica L Gutierrez,
Monika Borkowska,
Nancy F Scheraga,
Nancy L Rolli,
Nancy M Espinal,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas A Violand,
Nina Yang,
Niraj R Mehta, PhD,
Nisha C Patel,
Omotunde O Osunsanmi,
Paul L Bellamy,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Qiao Y Bobo,
Regina T Brown,
Richard D Manney,
Richard T Riggie,
Robert G Ruff,
Robert Jennings,
Rodney T Allnutt,
Rose Ashley,
Russell J Glapion,
Sandra Kershaw,
Sarah Adella Fave,
Sarah Forney,
Schultz,
Sherri J Liu,
Sheryl A Kochman,
Shirley H Isbill,
Shirley S Wen,
Sidney B Priesmeyer,
Simone E Pitts,
Sinai I Davis,
Stephanie T Durso,
Stephen D Brown,
Susan M Jackson,
Susan T Hadman,
Tania E Garcia,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Tawny L Colling,
Teresita C Mercado,
Thomas J Arista,
Tonia F Bernard,
Tyanna N Hadley,
Valerie C Reed,
Valerie Reed,
Wayne J Meyer,
Willy A Orantes,
Xiaohan Cai, PhD,
Xiaoping Guan,
Yvesna C Blaise,
Zakaria I Ganiyu
Jean M Kelahan's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more